Home › Blood Cancers › Ohio › Akron
Blood Cancers clinical trials in Akron, OH
4 studies for Blood Cancers are looking for participants at sites in and around Akron (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Summa Health System - Akron Campus, Akron
- Cleveland Clinic Akron General, Akron
- Summa Health System - Barberton Campus, Barberton · 7 mi away
- and 1 more
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
RecruitingPhase 1
- Gabrail Cancer Center, Canton · 21 mi away
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecruitingObservational study
- Childrens Hospital Medical Center of Akron, Akron
Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairment
RecruitingPhase 1
- Gabrail Cancer Center, Canton · 21 mi away
Blood Cancers trials in other cities
- Houston, TX46 studies
- New York City, NY26 studies
- Boston, MA25 studies
- Washington, DC19 studies
- Baltimore, MD18 studies
- Seattle, WA18 studies
- Los Angeles, CA17 studies
- Durham, NC16 studies
- Chicago, IL15 studies
- Philadelphia, PA14 studies
- Atlanta, GA13 studies
- Nashville, TN13 studies
Other studies in Akron
- Non-Small Cell Lung Cancer22 studies
- Lung Cancer16 studies
- Cancer (all types)13 studies
- Breast Cancer13 studies
- Prostate Cancer9 studies
- Acute Myeloid Leukemia8 studies
- Melanoma8 studies
- Small Cell Lung Cancer8 studies
- Metastatic Cancer8 studies
- Colorectal Cancer8 studies
- Steatotic Liver Disease7 studies
- Endometrial Cancer6 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.